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A carbapenem-resistant sequence type 512 (ST512) Klebsiella pneumoniae carbapenemase 3 (KPC-3)-producing K. pneumoniae
strain showing a novel variant plasmid content was isolated in Palermo, Italy, in 2014. ST512 is a worldwide successful clone as-
sociated with the spread of blaKPC genes located on the IncFIIk pKpQIL plasmid. In our ST512 strain, the blaKPC-3 gene was un-
usually located on an IncX3 plasmid, whose complete sequence was determined. Two copies of blaKPC-3::Tn4401a caused by in-
tramolecular transposition events were detected in the plasmid.
Extensively drug-resistant (XDR) and pandrug-resistant Kleb-siella pneumoniae carbapenemase (KPC)-producing K. pneu-
moniae strains of the hyperepidemic clonal complex 258
(CC258) are detected worldwide as hospital-acquired patho-
gens and are frequently responsible for outbreaks. In particu-
lar, sequence type 258 (ST258), ST512, ST11, and ST340 are the
most frequently detected variants of KPC-producing K. pneu-
moniae isolates (1, 2).
During May and June 2011, a countrywide Italian survey fo-
cusing on the diffusion of carbapenem-nonsusceptible K. pneu-
moniae isolates showed that the most frequent lineages belonged
to CC258 (ST258 or ST512) (3). The epidemiology of KPC-pro-
ducingK. pneumoniae in Palermo, Italy, also confirmed the emer-
gence of ST258 beginning in 2008 (4). More recently, a 6-month
surveillance performed inSicily suggested that amajor epidemiolog-
ical change is likely ongoing in this geographic area, with ST258 still
being prevalent but circulating along with several additional STs, in-
cluding ST307 andST273 (4). In particular, only one isolate of ST512
(i.e.,K. pneumoniae strain 45) was identified on a total of 94 KPC-
producingK. pneumoniae strains (4). This unique isolate of ST512
was further investigated and described in this study.
As shown in Table 1, the ST512 K. pneumoniae 45 strain
showed an XDR phenotype (4). It was screened by PCR for the
following plasmid-mediated quinolone resistance and -lacta-
mase genes: qnrA, qnrB, qnrC, qnrD, qnrS, aac(6=)-Ib-cr, qepA,
oqxAB, blaKPC, blaVIM, blaNDM, blaOXA-48, blaOXA, blaSHV, blaTEM,
blaLAP, blaCTX-M, and blaCMY (5–8). Positive amplicons under-
went Sanger DNA sequencing to identify the variant genes. K.
pneumoniae 45was positive for the blaKPC-3, blaOXA-1, blaCTX-M-15,
blaTEM-1, aac(6=)-Ib-cr, blaSHV-11, and oqxAB genes. The imple-
mentation of the PCR-based replicon typing (PBRT) kit (Dia-
theva) indicated that plasmids carried by strain 45 were not type-
able. Therefore, the blaKPC-3-carrying plasmid was transformed in
Escherichia coli DH5 competent cells (Invitrogen) and selected
on Luria-Bertani agar plates (Sigma) containing ampicillin (50
g/ml). The transformants were then screened by PCR for the
presence of blaKPC genes. Plasmid DNA of one representative
blaKPC-3-positive transformant (named p45)was purified using an
Invitrogen plasmid midi kit (Invitrogen) and fully sequenced. A
shotgun librarywas obtained, and sequencingwas performedwith
the 454-GS Junior platform, according to the standard sequencing
procedure (RocheDiagnostics). Plasmid coveragewas80. The
reads were aligned and assembled using the Newbler assembler soft-
ware version 2.0.01.14 (Roche Diagnostics). We found that plasmid
p45 was split into three contigs, and the complete sequence was re-
constructed by a PCR-based gap closure method. Open reading
frames (ORFs) were predicted and annotated using the Artemis soft-
ware (Wellcome Trust Sanger Institute, United Kingdom). Each
predicted protein was compared against the protein database
using BLASTP (http://blast.ncbi.nlm.nih.gov/Blast.cgi). The
gene sequences were compared and aligned with GenBank data
using BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi). The
IncX3 plasmids pKpS90 and pIncX-SHV (GenBank accession
no. JX461340 and JN247852, respectively) were used as refer-
ences for annotation and comparative analyses.
As shown in Fig. 1, our results indicated that p45 is 63,203 bp in
size and shows the typical IncX3 scaffold, including the replicase
gene, tax, and pilX gene clusters (9). The blaKPC-3 gene is located in
the Tn3-like element Tn4401a (10). However, we observed that
two copies of Tn4401a were present at a distance of 8,658 bp
within the IncX3 plasmid scaffold of p45.
One copy of Tn4401a was integrated within an IS3000-a1 ele-
ment, which was interrupted by the blaKPC-3::Tn4401a insertion.
The duplication of a 5-bp sequence was identified at the site of
integration, immediately flanking the inverted repeat right (IRR)
and inverted repeat left (IRL) of Tn4401a. The blaSHV-11 gene was
identified 4 kb from the blaKPC-3::Tn4401a integration site, fol-
lowed by an IS26 element. The same structure carrying IS26-
blaSHV-11-IS3000 was previously detected in plasmid pIncX-SHV
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FIG 1 Major structural features of plasmids p45, pKpS90, and pIncX-SHV. Predicted open reading frames (ORFs) on plasmids are represented by white arrows.
The ORFs of p45 were identified in this study; the ORFs of pKpS90 and pIncX-SHV were deduced from GenBank accession numbers JX461340 and JN247852,
respectively. The transposase genes of the Tn44011a transposons flanked by IRR and IRL (thick black lines) are indicated by gray arrows; the blaKPC-3 genes inside
Tn4401a are indicated by black arrows. The DNA sequences of duplicated target sites are indicated above the IRR and IRL. The ygbK, IS3000, and topB genes
targeted by Tn4401a transposition events that occurred in the different plasmids are indicated by arrows filled with stripes, dots, and black squares, respectively.
TABLE 1 Antimicrobial susceptibility profiles of the original KPC-producing K. pneumoniae isolates and transformantsa
MIC (g/ml) (category) forc
Antibiotic(s)











Piperacillin-tazobactam 128 (R) 128 (R) 128 (R) 128 (R) 32 (S)
Ticarcillin-clavulanate 256 (R) 256 (R) 256 (R) 256 (R) 256 (R)
Cefoxitin 128 (NA) 128 (NA) 128 (NA) 16 (NA) 16 (NA)
Cefpodoxime 64 (R) 64 (R) 64 (R) 64 (R) 64 (R)
Ceftriaxone 256 (R) 256 (R) 256 (R) 32 (R) 4 (R)
Cefotaxime 128 (R) 128 (R) 128 (R) 8 (R) 4 (R)
Cefotaxime-clavulanate 128 (NA) 128 (NA) 128 (NA) 4 (NA) 0.25 (NA)
Ceftazidime 256 (R) 256 (R) 256 (R) 64 (R) 16 (R)
Ceftazidime-clavulanate 256 (NA) 256 (NA) 256 (NA) 32 (NA) 4 (NA)
Cefepime 32 (R) 32 (R) 32 (R) 8 (R) 2 (S)
Aztreonam 32 (R) 32 (R) 32 (R) 32 (R) 32 (R)
Imipenem 32 (R) 32 (R) 32 (R) 2 (S) 0.25 (S)
Meropenem 16 (R) 16 (R) 16 (R) 1 (S) 0.5 (S)
Ertapenem 8 (R) 8 (R) 8 (R) 1 (I) 0.125 (S)
Doripenem 4 (R) 4 (R) 4 (R) 0.5 (S) 0.25 (S)
Gentamicin 1 (S) 0.5 (S) 2 (S) 0.5 (S) 0.5 (S)
Tobramycin 16 (R) 16 (R) 16 (R) 0.5 (S) 0.5 (S)
Amikacin 16 (I) 16 (I) 32 (R) 2 (S) 2 (S)
Ciprofloxacin 4 (R) 4 (R) 4 (R) 0.125 (S) 0.125 (S)
Levofloxacin 16 (R) 16 (R) 16 (R) 0.5 (S) 0.5 (S)
Trimethoprim-sulfamethoxazole 2 (S) 2 (S) 2 (S) 0.25 (S) 0.25 (S)
Colistin 4 (R) 0.25 (S) 8 (R) 0.125 (S) 0.125 (S)
Polymyxin B 1 (NA) 0.5 (NA) 8 (R) 0.125 (S) 0.125 (S)
Doxycycline 8 (NA) 8 (NA) 4 (NA) 1 (NA) 1 (NA)
Minocycline 16 (NA) 8 (NA) 4 (NA) 1 (NA) 1 (NA)
Tigecycline 0.5 (S) 0.5 (S) 0.5 (S) 0.125 (S) 0.125 (S)
a R, resistant; I, intermediate; S, susceptible; NA, not applicable.
b K. pneumoniae strains ST512 and ST258-44 were previously described in Capone et al. (18) and Bonura et al. (4).
c According to the EUCAST 2015 criteria. MICs were obtained by implementing ESB1F and GNX2F plates (Trek Diagnostics).
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(11; GenBank accession no. JN247852). In a similar plasmid (i.e.,
pKpS90), blaKPC-2::Tn4401a was integrated in the same region as
p45 butwithin a different site, causing the interruption of the ygbK
gene (12). The progenitor of p45 was therefore a pIncX-SHV-like
plasmid carrying the blaSHV-11 gene (11).
The second copy of Tn4401a in p45 was integrated in topB (a
gene constantly present in all IncX3 plasmids) and in opposite
orientation compared to that of the first transposon (Fig. 1). The
target site duplication was also identified in this site, adjacent to
the inverted repeats of the transposon. It is plausible that the ac-
quisition of the second Tn4401a in p45 occurred by intramolecu-
lar transposition. In the literature, the simultaneous presence of two
blaKPC copies located in trans on different plasmids in the same bac-
terial host was previously reported in several collections (13–16).
However, only two examples of in cis blaKPC genes were previously
described and differed from the arrangement described for p45. Two
blaKPC-3::Tn4401a copies were identified in MNCRE44, an extraint-
estinal pathogenic E. coli strain belonging to the ST131H30R sub-
clade and found in the United States (13). Its plasmid (pMN-
CRE44_5) was a 116-kb hybrid of IncX3 and IncFIA(HI1)
plasmids, and the two transposon copies were located as one copy
for each of the two fused plasmid portions (13). The duplication of
the similar transposon blaKPC-2::Tn4401b was described for the
IncN plasmid S9 from K. pneumoniae in the United States (17).
The MICs for several antibiotics for KPC-producing K.
pneumoniae strains of ST512 and ST258 carrying blaKPC-3 on
pKpQIL (18), those of KPC-producing K. pneumoniae 45 (ST512
and with IncX3) and those of their corresponding E. coli DH5
transformants, were determined implementing the microdilution
ESB1F and GNX2F plates (Trek Diagnostics) (Table 1). As result,
we noted that the E. coli DH5 transformant carrying the IncX3
plasmid with two copies of blaKPC-3::Tn4401a showed signifi-
cantly increased MICs for carbapenems, cephalosporins, and
-lactam–-lactamase inhibitor combinations compared to those
of the transformant carrying the classical pKpQIL plasmid. This
phenomenon was not observed for the original K. pneumoniae
strains of different STs and possessing different blaKPC genetic
backgrounds. The difference in MICs may be due not only to the
double copy of the blaKPC genes and their levels of gene expression
(14) but also to different copy numbers of IncX3 and pKpQIL.
In conclusion, our study describes the change in the typical plas-
mid content of ST512 K. pneumoniae: the worldwide-described
pKpQIL plasmid carrying blaKPC (19; GenBank accession no.
GU595196) was replaced by an IncX3 plasmid carrying two copies
of blaKPC-3::Tn4401a. The change in plasmid type in K. pneu-
moniae strain 45 might represent an important evolution of the
ST512 lineage.
Nucleotide sequence accession number.TheGenBank file for
K. pneumoniae strain ST512 plasmid p45-IncX3 was compiled
using Sequin (http://www.ncbi.nlm.nih.gov/Sequin/) and depos-
ited at the NCBI GenBank under accession no. KT362706.
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